We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.21B
AUM Growth
+$110M
Cap. Flow
-$79.3M
Cap. Flow %
-3.59%
Top 10 Hldgs %
22.7%
Holding
3,121
New
66
Increased
341
Reduced
717
Closed
30

Sector Composition

Rank Sector Weight
1 Technology 17.76%
2 Consumer Discretionary 10.46%
3 Healthcare 9.6%
4 Financials 9.53%
5 Industrials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCPH
3001
DELISTED
scPharmaceuticals
SCPH
$4K ﹤0.01%
475
SPYM
3002
State Street SPDR Portfolio S&P 500 ETF
SPYM
$168B
$4K ﹤0.01%
113
SWKH
3003
DELISTED
SWK Holdings
SWKH
$4K ﹤0.01%
395
TCI icon
3004
Transcontinental Realty Investors
TCI
$318M
$4K ﹤0.01%
147
TH icon
3005
Target Hospitality
TH
$1.61B
$4K ﹤0.01%
2,913
TPHD icon
3006
Timothy Plan High Dividend Stock ETF
TPHD
$369M
$4K ﹤0.01%
214
+1
+0.5% +$23
TPIF icon
3007
Timothy Plan International ETF
TPIF
$266M
$4K ﹤0.01%
178
+1
+0.6% +$24
VERO
3008
DELISTED
Venus Concept
VERO
$4K ﹤0.01%
10
SBT
3009
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$4K ﹤0.01%
1,471
AE
3010
DELISTED
Adams Resources & Energy Inc
AE
$4K ﹤0.01%
194
SCTL
3011
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$4K ﹤0.01%
1,686
EXPR
3012
DELISTED
Express, Inc.
EXPR
$4K ﹤0.01%
305
RVLP
3013
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$4K ﹤0.01%
800
PHAS
3014
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$4K ﹤0.01%
1,211
GBL
3015
DELISTED
GAMCO Investors, Inc.
GBL
$4K ﹤0.01%
342
RDS.A
3016
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$4K ﹤0.01%
+187
New +$5.66K
KNOW
3017
DELISTED
Direxion All Cap Insider Sentiment Shares
KNOW
$4K ﹤0.01%
145
ESTE
3018
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$4K ﹤0.01%
1,654
REV
3019
DELISTED
Revlon, Inc.
REV
$4K ﹤0.01%
576
BBCP icon
3020
Concrete Pumping Holdings
BBCP
$479M
$3K ﹤0.01%
980
BBH icon
3021
VanEck Biotech ETF
BBH
$429M
$3K ﹤0.01%
20
BH.A icon
3022
Biglari Holdings Class A
BH.A
$1.23B
$3K ﹤0.01%
6
BRID icon
3023
Bridgford Foods
BRID
$57.4M
$3K ﹤0.01%
153
BSVN icon
3024
Bank7 Corp
BSVN
$495M
$3K ﹤0.01%
280
DEO icon
3025
Diageo
DEO
$52.2B
$3K ﹤0.01%
27

Similar funds

Ameritas Investment Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Ameritas Investment Partners held 3,121 positions worth $2.21B, up 5.2% from $2.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ameritas Investment Partners withdrew a net $79.3M in Q3 2020, closing 30 positions and reducing 717 holdings. Its most notable exit was Caesars Entertainment Corporation, an estimated $1.97M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Ameritas Investment Partners opened a new position in Jazz Pharmaceuticals worth $2.24M.

  • Ameritas Investment Partners's largest Q3 2020 buy was Jazz Pharmaceuticals: 15,701 shares worth $2.24M.
  • Ameritas Investment Partners added most to Invesco QQQ Trust in Q3 2020, an estimated $3.73M increase.
  • Ameritas Investment Partners's biggest Q3 2020 reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, cutting an estimated $6.14M.
  • Ameritas Investment Partners fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $1.97M.
  • Ameritas Investment Partners's ten largest holdings make up 23% of its $2.21B portfolio in Q3 2020.
  • Ameritas Investment Partners opened 66 new positions and closed 30 in Q3 2020.
  • Ameritas Investment Partners's portfolio value rose 5.2% quarter-over-quarter to $2.21B.

Based on Ameritas Investment Partners's 13F filing for Q3 2020, filed 13 Nov 2020.